CAF-derived BGN regulates ECM remodeling and immune response in breast cancer by facilitating the interaction of CAFs with immune cells, inhibiting NK cells, CD8+ cells, and MDSCs while stimulating tumor-favorable macrophage activation [136]. The gene discussed is CD8A; the disease is neoplasm.